• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Pillo Health raises $11M to continue development of voice-enabled platform for the home

Share:

June 4, 2019

Various investors, including Stanley Black & Decker’s corporate venture capital arm, Samsung Ventures, Civilization Ventures and others took part in the round.

Boston-based technology company Pillo Health has nabbed $11 million in Series A funding, according to a news release.

Stanley Black & Decker’s corporate venture capital arm led the round, and Samsung Ventures participated. Existing investors, including BioAdvance, Civilization Ventures, Hackensack Meridien Health System’s Innovation Center Fund and Hikma Ventures (the corporate ventures capital arm of Hikma Pharmaceuticals) took part in the round as well.

Pillo Health is focused on helping patients manage their health at home and letting organizations bring digital solutions to the home.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The company offers an Amazon Alexa-like robot that is placed in a patient’s home. It can answer questions and learn from patients to generate real-time health data. In addition to connecting patients with their doctors, the HIPAA-compliant, voice-first platform can dispense patients’ medications and digitally coordinate prescription refills.

The Pillo platform gives providers and payers the opportunity to gain insight into a patient’s health status. It also enables home health agencies and care teams to offer better care in the patient’s home. Other goals of the offering include improving medication adherence and reducing medication-related complications.

With the $11 million in funding, the Boston startup intends to keep developing its platform and create additional voice-first experiences for organizations that want to bring digital solutions to patients. Plus, Pillo is hiring employees to work in its offices in Boston and Genoa, Italy.

“We look forward to the continued evolution of the Pillo Health platform as we work with organizations addressing the management of chronic conditions for patients at home,” said Pillo Health co-founder and CEO Emanuele Musini in a statement. “Stanley Black & Decker and Samsung have made a strong commitment to the health and wellness of millions of Americans looking to remain independent longer, with a focus on tailoring voice-first technologies for their customers and revolutionizing the way healthcare is delivered into the home.”

In addition to the funding news, the Boston company said it is working with Stanley Black & Decker to launch Pria by BLACK+DECKER, a tool powered by the Pillo Health platform. Stanley Black & Decker debuted the offering at CES in Las Vegas earlier this year. This summer, it will be available for consumer purchase online.

Date: June 04, 2019

Source: MedCityNews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • mHealth Study Uses Wearables, AI to Detect Internalizing DisordersmHealth Study Uses Wearables, AI to Detect Internalizing Disorders
  • 94% of Healthcare Execs Say AI, Blockchain Have Advanced Innovation94% of Healthcare Execs Say AI, Blockchain Have Advanced Innovation
  • Analysis: August Health IT M&A Activity; Public Company PerformanceAnalysis: August Health IT M&A Activity; Public Company Performance
  • UK Launches World’s First COVID-19 Human Challenge StudyUK Launches World’s First COVID-19 Human Challenge Study
  • 7 Trends Impacting the Design of Healthcare Environments in 20207 Trends Impacting the Design of Healthcare Environments in 2020
  • Acadia Professional, LLC Acquires Toro Risk Consulting Group, LLCAcadia Professional, LLC Acquires Toro Risk Consulting Group, LLC
  • UPMC Launches New Telemedicine Company to Tackle Infectious DiseasesUPMC Launches New Telemedicine Company to Tackle Infectious Diseases
  • What Will It Take to Improve Recruitment for Clinical Trials?What Will It Take to Improve Recruitment for Clinical Trials?

Trending This Week

  • Novartis Drops Eye Disease Gene Therapy from $800M Gyroscope Acquisition
  • GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies GroupGelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security Market
  • Life Launches AI Clinical Trial Matching Assistant for Cancer
  • 79% of Healthcare Execs Believe Most Drug Diversion Goes Undetected
  • Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine
  • FDA Releases Updated Final Guidance for its Breakthrough Devices Program

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications